Transaction #2270 · Form 4 · 0001817160-25-000003
Nurix Therapeutics, Inc. · Stock award · Restricted Stock Units
Nurix Therapeutics, Inc. · Transacted October 14, 2025 · Filed October 23, 2025
What does this filing report?
An SEC Form 4 filing for Nurix Therapeutics, Inc. records a stock award involving Restricted Stock Units on October 14, 2025. The reported quantity was 20,000. The filing date is October 23, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Nurix Therapeutics, Inc.
- Company CIK
- 0001549595
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 20,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 20,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 23, 2025, 7:04 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Hansen Gwenn ↗
Chief Scientific Officer
CIK 0001817160
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 20,000
- Conversion / exercise price
- 0
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F2
- The RSUs will vest on the second anniversary of the date of grant, subject to the Reporting Person's continuous services to the Issuer from the date of grant through such vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- F3
- RSUs do not expire; they either vest or are canceled prior to the vest date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.